We would like to welcome, former Abbott/AbbVie Exec, Dr. Gayle Kirkpatrick, as she joins rMark Bio’s Advisory Board. Dr. Kirkpatrick is an accomplished executive with 25+ years of experience in Fortune 100 healthcare corporations and major academic research institutions. Her expertise and and former contributions to strategic planning, industry analysis, and due diligence for previous clients from early stage biotechnology companies to fully integrated pharmaceutical companies will be invaluable.
“CHICAGO, Feb. 8, 2018 /PRNewswire/ — rMark Bio is pleased to announce that Dr. Gayle Kirkpatrick has joined their Advisory board. The Chicago-based life science SaaS company, which delivers a suite of thought leader engagement applications atop their patented analytics platform, is elated to work with Gayle. Working alongside rMark Bio’s leadership team, Gayle is committed to developing plans to expand the adoption of their business intelligence solution for biopharmaceutical and other companies around the world.”
Keep up to date with rMark by following us on our social channels: